Sanofi-sponsored Scientific Abstracts and Presentations from the American Diabetes Association (ADA) 80th Annual Scientific Sessions

A Virtual Experience

June 12-16, 2020

Lixisenatide

1421-P: The Impact of Blood Pressure on Risk of Death is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event

M.O. Wijkman, B. Claggett, R. Diaz, H.C. Gerstein, A. Kober, E. Lewis, A.P. Maggioni, E. Wolsk, D. Aguilar, R. Bentley-Lewis, J.J. McMurray, J.L. Probstfield, M.C. Riddle, J.C. Tardif, S. Solomon, M.A. Pfeffer

Diabetes management

T1 Diabetes

851-P: Technology Use by Age and Region in Adults with Type 1 Diabetes (T1D) in the SAGE Study

S. Edelman, D. Bruttomesso, K. Close, A.G.D. Vianna, F. Lauand, S. Brette, E. Renard

1625-P: Association of Patient- and Disease-Related Factors with Glycemic Target Achievement in Type 1 Diabetes (T1D) in the SAGE Study

J. Seufert, H. Ikegami, S. Brette, V. Pilorget, F. Lauand, E.G. Wilmot, E. Renard, J.J. Gagliardino

1626-P: Differences in Patient-Reported Outcomes (PROs) by Age and Region in Adults with Type 1 Diabetes (T1D) in the SAGE Study

L. Berard, F.J. Ampudia-Blasco, S. Brette, D. Bruttomesso, K. Close, H. Ikegami, D. Jurišić-Eržen, F. Lauand, A. Peters, V. Pilorget, B. Ramanathan, E. Renard, E.G. Wilmot, A. Roborel de Climens

1627-P: Real-World Comparison of Acute Complications in Adult Patients with Type 1 Diabetes in US and European Registries

F.L. Zhou, J. Grimsmann, J. Pettus, W. Kerner, K. Miller, L. Stechemesser, S. Edeman, A.M. Ibald-Mulli, R.W. Holl

1629-P: Association of Patient-Reported Outcomes (PROs) Scores with Glycemic Target Achievement in Type 1 Diabetes (T1D) in the SAGE Study

E.G. Wilmot, F.J. Ampudia-Blasco, L. Berard, S. Brette, L.E. Calliari, E. Fitts, K. Close, J.J. Gagliardino, F. Lauand, A. Peters, E. Renard, A. Roborel de Climens, J. Seufert

T2 Diabetes

1029-P: Effectiveness of Premix Insulin (Premix) in Type 2 Diabetes (T2D): A Retrospective UK Cohort Study

E.B. Jude, A. Ali, R. Emral, N. Nanda, R. Lubwama, K.D. Palmer, A. Shaunik, P. Raskin, F. Gómez Peralta, C. Trescoli

1582-P: Glycemic Change from Baseline in the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

R. Ghosh, A.K. Das, A. Mithal, S. Joshi, K.M. Prasanna Kumar, S. Kalra, A. Gopalakrishnan Unnikrishnan, H. Thacker, B. Sethi, S. Mohanasundaram, S.K. Menon, A. Nair, N. Rais, S. Kumar Wangnoo, S. Chowdhury, A.H. Zargar

1588-P: Therapy Trends in Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

R. Ghosh, A.K. Das, A. Mithal, S. Joshi, K.M. Prasanna Kumar, S. Kalra, A. Gopalakrishnan Unnikrishnan, H. Thacker, B. Sethi, S. Mohanasundaram, S.K. Menon, A. Nair, N. Rais, S. Kumar Wangnoo, S. Chowdhury, A.H. Zargar

2258-PUB: Impact of Cardiovascular (CV) Risk Factors During the Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

R. Ghosh, A.K. Das, S. Joshi, A. Mithal, K.M. Prasanna Kumar, S. Kalra, A. Gopalakrishnan Unnikrishnan, H. Thacker, B. Sethi, S. Mohanasundaram, S.K. Menon, A. Nair, N. Rais, S. Kumar Wangnoo, S. Chowdhury, A.H. Zargar

2271-PUB: Rate of Diabetes Complications During the Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

R. Ghosh, A.K. Das, S. Joshi, A. Mithal, K.M. Prasanna Kumar, S. Kalra, A. Gopalakrishnan Unnikrishnan, H. Thacker, B. Sethi, S. Mohanasundaram, S.K. Menon, A. Nair, N. Rais, S. Kumar Wangnoo, S. Chowdhury, A.H. Zargar

Information is provided for scientific purposes only and may be outside the current labelling of the product. Sanofi does not recommend the use of any products in any manner inconsistent with that described in the full prescribing information. Please consult the prescribing information in your country of practice, as it can vary from country to country.

Availability of posters and/or abstracts on this site will coincide with ADA’s embargo policy.